Spire Healthcare Group Plc (SPI)
London Exchange · UK · prices in GBX · close of 20 Oct 2026
Key indicators
| Last close | GBX 247.50 |
|---|---|
| 52-week range | 139.84 – 249.50 |
| Return, 1 month / 3 months | +0.8% / +11.5% |
| Return, 1 year / 3 years | +6.7% / +19.3% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 58.4% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 636.90M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Spire Healthcare Group runs private hospitals and clinics across the United Kingdom, providing elective surgery, diagnostics, outpatient consultations and cancer care. Its hospitals serve people paying for treatment themselves, those covered by private medical insurance, and patients referred through arrangements with the National Health Service. The company is based in the United Kingdom and focuses on planned, non-emergency care delivered by consultants and clinical teams in its local hospital network.
On this site Spire Healthcare Group Plc appears as a stock on the London Exchange (UK), code SPI, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Spire Healthcare Group Plc (SPI) trades on the London Exchange in UK. It last closed at GBX 247.50 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,092 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.7% and over the last three months it rose 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.8% | ||
| From 52-week high | -0.2% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.5% | ||
| 6-month return | 51.8% | ||
| 12-month return, skipping the last month | 5.9% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 636.90M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 6 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.8% |
| 3 months | +11.5% |
| 6 months | +51.8% |
| 1 year | +6.7% |
| 3 years | +19.3% |
| 5 years | +8.8% |
Signals
| 50-day / 200-day average | 242.28 / 206.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2026 | GBP 0.0150 |
| 22 May 2025 | GBP 0.0230 |
| 23 May 2024 | GBP 0.0210 |
| 25 May 2023 | GBP 0.0050 |
| 28 May 2020 | GBP 0.0250 |
| 14 Nov 2019 | GBP 0.0130 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.